FDA issued a Warning Letter to Wockhardt Limited on 7/18/2013 for a later inspection.
483 Wockhardt Jan 2012

483 Wockhardt Jan 2012

Michael Charles FDA$119.00 - Available Now

FDA investigators audited the Wockhardt - Aurangabad, India facility and issued inspectional observations (via FDA 483) on 27 Jan 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Jan 2012
  • Location: Aurangabad, India
  • FEI: 3005289335
Add To Cart